autoevolution
 

Super Bowl XLV Tickets Auctioned by Cure Duchenne

The second GM brand to donate Super Bowl tickets to charity, Cadillac, announced today that the tickets it would be handing to Cure Duchenne would be auctioned by the charity, with the proceeds to benefit research that would help cure Duchenne, a progressive form of muscular dystrophy.

The tickets donated by Cadillac are more than just tickets to the XLV edition of the Super Bowl, which takes place on February 6 at Cowboys Stadium in North Texas. The donation comes in the form of packages, which include both hotel accommodations and a pair of tickets to the event.

The auction for the packages runs until January 24, on CharityBuzz (follow the link to see the auction details). The organization plans that with the money it raises from selling the packages it will help cure or ease the suffering of the 20,000 boys and young men are affected by Duchenne in the United States.

The disease is as serious as it gets, as most of those affected by it do not live to see adulthood. Those who have it are forced to be in a wheelchair by the age of 12 and become completely paralyzed by their late teens.

“Duchenne is a devastating muscle disease in children, and we hope to raise awareness and join in the fight,”
said Don Butler, vice president for Cadillac marketing. “The organization has an entrepreneurial spirit that Cadillac is drawn to as a brand. They are not afraid to create their own path of innovation toward new solutions and technologies.”
If you liked the article, please follow us:  Google News icon Google News Youtube Instagram
About the author: Daniel Patrascu
Daniel Patrascu profile photo

Daniel loves writing (or so he claims), and he uses this skill to offer readers a "behind the scenes" look at the automotive industry. He also enjoys talking about space exploration and robots, because in his view the only way forward for humanity is away from this planet, in metal bodies.
Full profile

 

Would you like AUTOEVOLUTION to send you notifications?

You will only receive our top stories